Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group
M Johansen, J Kuttesch, WA Bleyer, M Krailo… - Clinical cancer …, 2006 - AACR
Abstract Purpose: Vinorelbine (Navelbine) is an orally absorbable Vinca with broad
antitumor activity. It differs from other Vinca in that it is structurally modified on the …
antitumor activity. It differs from other Vinca in that it is structurally modified on the …
Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group
M Johansen, J Kuttesch, WA Bleyer… - … : an official journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose Vinorelbine (Navelbine) is an orally absorbable Vinca with broad antitumor activity.
It differs from other Vinca in that it is structurally modified on the catharanthine nucleus and …
It differs from other Vinca in that it is structurally modified on the catharanthine nucleus and …
[引用][C] Phase i evaluation of oral and intravenous vinorelbine in pediatric cancer patients: A report from the children's oncology group
M JOHANSEN, J KUTTESCH… - Clinical cancer …, 2006 - pascal-francis.inist.fr
Phase i evaluation of oral and intravenous vinorelbine in pediatric cancer patients : A report
from the children's oncology group CNRS Inist Pascal-Francis CNRS Pascal and Francis …
from the children's oncology group CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
M Johansen, J Kuttesch, WA Bleyer… - … Cancer Research: an …, 2006 - europepmc.org
Purpose Vinorelbine (Navelbine) is an orally absorbable Vinca with broad antitumor activity.
It differs from other Vinca in that it is structurally modified on the catharanthine nucleus and …
It differs from other Vinca in that it is structurally modified on the catharanthine nucleus and …